<html><body><h2>Case: 2521654</h2><h3> CDS Time: 1957-05-17</h3>
<patient name=2521654>
57.0 year old White_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">57</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">180</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1957-5-15</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">50</td><td width="200">1957-4-20</td></tr>
<tr><td width="200">Chloride</td><td width="200">101.0</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">35</td><td width="200">1957-4-20</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">74</td><td width="200">1957-3-28</td></tr>
<tr><td width="200">BNP</td><td width="200">20487.0</td><td width="200">1957-4-19</td></tr>
<tr><td width="200">Weight</td><td width="200">149</td><td width="200">1957-3-28</td></tr>
<tr><td width="200">HbA1C</td><td width="200">10</td><td width="200">1957-4-20</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">48</td><td width="200">1957-4-20</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">89</td><td width="200">1957-4-20</td></tr>
<tr><td width="200">SGOT</td><td width="200">14</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">109</td><td width="200">1957-3-28</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Height</td><td width="200">69</td><td width="200">1957-3-28</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">89</td><td width="200">1957-4-20</td></tr>
<tr><td width="200">BUN</td><td width="200">38</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">HCT</td><td width="200">33</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">HGB</td><td width="200">11</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Sodium</td><td width="200">135</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Creatinine</td><td width="200">3.1</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">10</td><td width="200">1957-4-20</td></tr>
<tr><td width="200">Pulse</td><td width="200">83</td><td width="200">1957-3-28</td></tr>
<tr><td width="200">PLT</td><td width="200">108</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">WBC</td><td width="200">6</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1957-5-2</td></tr>
<tr><td width="200">SGPT</td><td width="200">29</td><td width="200">1957-5-16</td></tr>
<tr><td width="200">fluid retention</td><td width="200"></td><td width="200">1957-5-12</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1957-5-16</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1957-3-12</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Diabetes with renal manifestations</td><td width="200"></td><td width="200">1957-5-2</td></tr>
<tr><td width="200">Volume overload</td><td width="200"></td><td width="200">1957-5-12</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1957-5-16</td></tr>
<tr><td width="200">CKD</td><td width="200"></td><td width="200">1957-5-10</td></tr>
<tr><td width="200">Cardiomyopathy</td><td width="200"></td><td width="200">1957-5-10</td></tr>
<tr><td width="200">Pacemaker</td><td width="200"></td><td width="200">1957-5-5</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1957-5-8</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1957-5-16</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
</table>
<p><b>Medications:</b> aspirin(325.0) spironolactone(25.0) metolazone(5.0) torsemide(40.0) atorvastatin(10.0) nitrate(60.0) hydrochlorothiazide(25.0) hydralazine(75.0) digoxin(0.0) carvedilol(12.5) furosemide(80.0) Insulin(5.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1957-05-10</td>
<td width="200"> CKD()</td></tr>
<tr> <td width="200"></td>
<td width="200">1957-05-16</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1957-05-16</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1957-05-16</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1957-05-10</td>
<td width="200"> Cardiomyopathy()</td></tr>
<tr> <td width="200"></td>
<td width="200">1957-05-08</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1957-05-16</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr><td width="200">Pacemaker</td>
<td width="200">1957-05-05</td>
<td width="200"> Pacemaker()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1957-03-12</td>
<td width="200"> DM-Type2()</td></tr>
<tr> <td width="200"></td>
<td width="200">1957-05-02</td>
<td width="200"> Diabetes with renal manifestations()</td></tr>
<tr><td width="200">Creatinine > 1.5 and Male</td>
<td width="200"></td>
<td width="200"> Creatinine > 1.5 and Male[Creatinine(3.1/1957-5-16) && Sex(Male)]()</td></tr>
<tr><td width="200">Serum creatinine >=2</td>
<td width="200"></td>
<td width="200"> Serum creatinine >=2mg/dl[Creatinine(3.1/1957-5-16)]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1957-05-12</td>
<td width="200"> fluid retention()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1957-05-12</td>
<td width="200"> Volume overload()
<tr> <td width="200"></td>
<td width="200">1957-05-16</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA DM: Glycemic Control</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA DM: Glycemic Control: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(diabetes_mellitus)</i>]
<li>Creatinine > 1.5 and Male: [because <i> Creatinine > 1.5 and Male </i> evaluate to <b>true</b><i>(Creatinine(3.1/1957-5-16) && Sex(Male))</i>]
</ul>
<b>Scenario choice:</b> Insulin therapy only
<p>
<b>Goal:</b> HBA1C <= target(presence of target HBA1C)
<p><b>Reached goal?</b> failed(HbA1C(9.9/1957-4-20))
<p><b>Action Choices</b>
<ul>
<li><b>DM -  Insulin only</b><br>
<ul>
<li><b>Is patient high risk? If yes, refer <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])


<li><b>Metformin contraindicated, add Glipizide <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HbA1C > Target_HbA1c</i> evaluate to <b> true</b> because <i>HbA1C(9.9/1957-4-20)</i>)])
Add Glipizide
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>GLIPIZIDE(GLIPIZIDE)<ul><li>Relative indications:  DM-Type2(DM-Type2) <li>Sulfonylurea general info when prescribing(•	Efficacy ( HbA1c) a = 1.0 - 2.0 %
•	1st generation sulfonylureas are no longer commonly used.
•	No difference in long term efficacy or failure rate has been demonstrated among the sulfonylureas.
•	The preferred agents have shorter half-lives and inactive metabolites.
•	1st generation sulfonylureas are 100% renally eliminated. Chlorpropamide and tolazamide have active metabolites.
•	Glipizide, glyburide, and glimepiride are renally eliminated by 80 - 85%, 50%, and 60% respectively. All but glipizide have active metabolites.
•	Inexpensive)<li>preference: preferred</ul></ul></body></html>